Shimazaki S, Kuremoto K, Oyama S
Department of Pediatrics, Saiseikai Kawaguchi General Hospital Saitama.
No To Hattatsu. 1997 Jul;29(4):278-84.
We evaluated the efficacy of diazepam and chloral hydrate given rectally for the prophylaxis of recurrence of febrile seizure. The dose were 0.4 mg/kg for diazepam and 250 mg (for children younger than 3 years old) or 500 mg (for over 3 years old) for chloral hydrate. Another dose was given after an interval of 8 hours if body temperature continued to exceed 38.0 degrees C. Among the 452 patients with febrile seizures who visited our hospital from Jan. 1993 to Jun. 1995, 113 were studied who had at least one febrile episode in the follow-up period that extended over 6 months. These patients were divided into two groups: Group D (72 patients given diazepam) and Group C (41 patients given chloral hydrate). In group D and C, the numbers of febrile episodes were 238 and 167, and those of recurrent seizures 8 (3.8%) and 29 (20.4%), respectively. The recurrences rate was significantly higher in the latter group (p < 0.005). There was no statistical difference as to the mean dosage of diazepam or chloral hydrate between the patients with and without recurrence. The numbers of patients with seizure recurrence were 8 (11.1%) in group D and 12 (29.3%) in group C, being significantly larger in the latter (p < 0.005). Diazepam produced more adverse effects than chloral hydrate did. Thus diazepam suppositories for the prevention of recurrence of febrile seizures were more effective than chloral hydrate suppositories.
我们评估了直肠给予地西泮和水合氯醛预防热性惊厥复发的疗效。地西泮剂量为0.4mg/kg,水合氯醛剂量为250mg(3岁以下儿童)或500mg(3岁以上儿童)。如果体温持续超过38.0℃,8小时后再给予一次剂量。在1993年1月至1995年6月到我院就诊的452例热性惊厥患者中,对随访期超过6个月且至少有一次发热发作的113例患者进行了研究。这些患者分为两组:D组(72例给予地西泮)和C组(41例给予水合氯醛)。D组和C组的发热发作次数分别为238次和167次,复发惊厥次数分别为8次(3.8%)和29次(20.4%)。后一组的复发率显著更高(p<0.005)。复发患者与未复发患者之间地西泮或水合氯醛的平均剂量无统计学差异。D组癫痫复发患者有8例(11.1%),C组有12例(29.3%),后者显著更多(p<0.005)。地西泮产生的不良反应比水合氯醛更多。因此,用于预防热性惊厥复发的地西泮栓剂比水合氯醛栓剂更有效。